Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3558 | 1881 | 33.7 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
266 | 18634 | CHORDOMA//ANEURYSMAL BONE CYST//OSTEOID OSTEOMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OSTEOSARCOMA | Author keyword | 201 | 22% | 43% | 814 |
2 | METASTATIC OSTEOSARCOMA | Author keyword | 23 | 74% | 1% | 17 |
3 | SEZ CHEMIOTER IA | Address | 20 | 58% | 1% | 23 |
4 | MUSCULOSKELETAL ONCOL | Address | 18 | 26% | 3% | 59 |
5 | SEZIONE CHEMIOTER IA | Address | 15 | 88% | 0% | 7 |
6 | MULTIFOCAL OSTEOSARCOMA | Author keyword | 8 | 100% | 0% | 5 |
7 | MIFAMURTIDE | Author keyword | 5 | 55% | 0% | 6 |
8 | HIGH GRADE OSTEOSARCOMA | Author keyword | 4 | 67% | 0% | 4 |
9 | RIC ONCOL | Address | 4 | 23% | 1% | 16 |
10 | COPS3 | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OSTEOSARCOMA | 201 | 22% | 43% | 814 | Search OSTEOSARCOMA | Search OSTEOSARCOMA |
2 | METASTATIC OSTEOSARCOMA | 23 | 74% | 1% | 17 | Search METASTATIC+OSTEOSARCOMA | Search METASTATIC+OSTEOSARCOMA |
3 | MULTIFOCAL OSTEOSARCOMA | 8 | 100% | 0% | 5 | Search MULTIFOCAL+OSTEOSARCOMA | Search MULTIFOCAL+OSTEOSARCOMA |
4 | MIFAMURTIDE | 5 | 55% | 0% | 6 | Search MIFAMURTIDE | Search MIFAMURTIDE |
5 | HIGH GRADE OSTEOSARCOMA | 4 | 67% | 0% | 4 | Search HIGH+GRADE+OSTEOSARCOMA | Search HIGH+GRADE+OSTEOSARCOMA |
6 | COPS3 | 4 | 75% | 0% | 3 | Search COPS3 | Search COPS3 |
7 | DOXORUBICIN BINDING | 3 | 100% | 0% | 3 | Search DOXORUBICIN+BINDING | Search DOXORUBICIN+BINDING |
8 | MULTICENTRIC OSTEOSARCOMA | 3 | 60% | 0% | 3 | Search MULTICENTRIC+OSTEOSARCOMA | Search MULTICENTRIC+OSTEOSARCOMA |
9 | PEDIATRIC OSTEOSARCOMA | 3 | 42% | 0% | 5 | Search PEDIATRIC+OSTEOSARCOMA | Search PEDIATRIC+OSTEOSARCOMA |
10 | EXTRAPULMONARY METASTASIS | 2 | 67% | 0% | 2 | Search EXTRAPULMONARY+METASTASIS | Search EXTRAPULMONARY+METASTASIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NONMETASTATIC OSTEOSARCOMA | 218 | 75% | 8% | 158 |
2 | OSTEOGENIC SARCOMA | 153 | 33% | 20% | 380 |
3 | HIGH GRADE OSTEOSARCOMA | 143 | 61% | 8% | 151 |
4 | OPERABLE OSTEOSARCOMA | 78 | 78% | 3% | 52 |
5 | SCANDINAVIAN SARCOMA GROUP | 50 | 75% | 2% | 36 |
6 | STUDY GROUP PROTOCOLS | 49 | 61% | 3% | 51 |
7 | METASTATIC OSTEOSARCOMA | 48 | 67% | 2% | 44 |
8 | LOCALIZED OSTEOSARCOMA | 40 | 82% | 1% | 23 |
9 | DELAYED SURGERY | 39 | 44% | 4% | 67 |
10 | OSTEO SARCOMA | 36 | 19% | 9% | 167 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Osteosarcoma treatment - Where do we stand? A state of the art review | 2014 | 47 | 76 | 88% |
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand? | 2011 | 61 | 95 | 73% |
New targets and approaches in osteosarcoma | 2013 | 43 | 92 | 47% |
Primary bone osteosarcoma in the pediatric age: State of the art | 2006 | 207 | 130 | 47% |
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma | 2007 | 87 | 31 | 84% |
Osteosarcoma (Osteogenic sarcoma) | 2007 | 92 | 12 | 75% |
PROGNOSTIC FACTORS IN OSTEOSARCOMA - A CRITICAL-REVIEW | 1994 | 243 | 17 | 94% |
A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma | 2013 | 18 | 32 | 59% |
Current treatment of osteosarcoma | 2001 | 144 | 233 | 59% |
Biology and therapeutic advances for pediatric osteosarcoma | 2004 | 254 | 202 | 33% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SEZ CHEMIOTER IA | 20 | 58% | 1.2% | 23 |
2 | MUSCULOSKELETAL ONCOL | 18 | 26% | 3.1% | 59 |
3 | SEZIONE CHEMIOTER IA | 15 | 88% | 0.4% | 7 |
4 | RIC ONCOL | 4 | 23% | 0.9% | 16 |
5 | BONE TUMOR REFERENCE | 4 | 33% | 0.5% | 9 |
6 | CLIN COOPERAT GRP OSTEOSARCOMA | 4 | 36% | 0.4% | 8 |
7 | SERV CHEMIOTER IA | 3 | 57% | 0.2% | 4 |
8 | COOPERAT OSTEOSARKOMSTUDIENGRP | 3 | 100% | 0.2% | 3 |
9 | SERV CHEMOTHER Y | 2 | 38% | 0.3% | 5 |
10 | COSS STUDY | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000175701 | BIZARRE PAROSTEAL OSTEOCHONDROMATOUS PROLIFERATION//PAROSTEAL OSTEOSARCOMA//NORAS LESION |
2 | 0.0000150161 | EXTRASKELETAL OSTEOSARCOMA//PRIMARY PULMONARY OSTEOSARCOMA//PRIMARY OSTEOSARCOMA |
3 | 0.0000148834 | SOFT TISSUES NEOPLASMS//BONE NEOPLASMS MR//MUSCLES NEOPLASMS |
4 | 0.0000134071 | ROTATIONPLASTY//HEMIPELVECTOMY//LIMB SALVAGE |
5 | 0.0000111352 | CANINE OSTEOSARCOMA//ANIM CANC//LIMB SPARING |
6 | 0.0000091379 | ISOLATED LUNG PERFUSION//PULMONARY METASTASECTOMY//PULMONARY METASTASES |
7 | 0.0000073393 | 7 HYDROXYMETHOTREXATE//GLUCARPIDASE//HIGH DOSE METHOTREXATE |
8 | 0.0000066021 | EWINGS SARCOMA//EWING SARCOMA//PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR |
9 | 0.0000056855 | TRABECTEDIN//ET 743//YONDELIS |
10 | 0.0000044739 | CHONDROSARCOMA//MESENCHYMAL CHONDROSARCOMA//EXTRASKELETAL MYXOID CHONDROSARCOMA |